Proactive compared with passive adverse event recognition: calcium channel blocker-associated edema

Area of Science:

• Pharmacovigilance
• Clinical Trial Safety Monitoring
• Adverse Drug Event Detection

Background:

• Adverse event monitoring is crucial for drug safety and clinical practice.
• Passive surveillance (e.g., voluntary reporting) often underreports adverse events.
• Calcium channel blockers (CCBs) are commonly used antihypertensives with known side effects.

Purpose of the Study:

• To compare passive versus proactive surveillance for detecting adverse events.
• To examine the incidence of peripheral edema associated with dihydropyridine CCBs.
• To highlight the impact of surveillance methods on reported adverse event frequencies.

Main Methods:

• Literature search (2000-2007) on MEDLINE for randomized trials and meta-analyses.
• Focused on dihydropyridine CCB-induced peripheral edema.
• Compared incidence data based on different adverse event assessment methods.

Main Results:

• Proactive surveillance, especially active patient questioning, yielded higher incidence rates of peripheral edema.
• Edema incidence in trials with active questioning exceeded that in prescribing information.
• The method of edema assessment significantly influenced reported incidence rates.

Conclusions:

• Proactive surveillance methods, including patient solicitation and direct examination, are more effective in detecting adverse events.
• The incidence of CCB-induced peripheral edema is likely underestimated in passive reporting systems.
• Accurate adverse event reporting is essential for informed clinical and prescribing decisions.